相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group
Eric J. Chow et al.
CANCER (2022)
Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells
Rachel E. Nicoletto et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2022)
The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
Rony Abdi Syahputra et al.
MOLECULES (2022)
Recent Insights into Therapy Resistance in Osteosarcoma
Zachary D. Prudowsky et al.
CANCERS (2021)
Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics
Archana Adhikari et al.
PHARMACEUTICALS (2021)
Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
Agata Bikiewicz et al.
ESC HEART FAILURE (2021)
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Pushkar Singh Rawat et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review
Izabela Koss-Mikolajczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician
Ekaterina Yu Podyacheva et al.
FRONTIERS IN PHARMACOLOGY (2021)
Hydroxytyrosol Selectively Affects Non-Enzymatic Glycation in Human Insulin and Protects by AGEs Cytotoxicity
Ivana Sirangelo et al.
ANTIOXIDANTS (2021)
Olive Polyphenols: Antioxidant and Anti-Inflammatory Properties
Monica Bucciantini et al.
ANTIOXIDANTS (2021)
Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial
A. Mecinaj et al.
CARDIO-ONCOLOGY (2021)
Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity
Allison Padegimas et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2020)
Healthy Effects of Plant Polyphenols: Molecular Mechanisms
Manuela Leri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Red orange and lemon extract prevents the renal toxicity induced by ochratoxin A in rats
Sara Damiano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition
Jaewon Oh et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p
Xiaoxue Yu et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
Balaraman Kalyanaraman
REDOX BIOLOGY (2020)
Hydroxytyrosol Inhibits Protein Oligomerization and Amyloid Aggregation in Human Insulin
Ivana Sirangelo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Vanillin Prevents Doxorubicin-Induced Apoptosis and Oxidative Stress in Rat H9c2 Cardiomyocytes
Ivana Sirangelo et al.
NUTRIENTS (2020)
Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?
Cun Liu et al.
PHARMACOLOGICAL RESEARCH (2020)
Hydroxytyrosol, Tyrosol and Derivatives and Their Potential Effects on Human Health
Ana Karkovic Markovic et al.
MOLECULES (2019)
Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway
Hui Lin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
Nadine Wenningmann et al.
MOLECULAR PHARMACOLOGY (2019)
Oxidative stress injury in doxorubicin-induced cardiotoxicity
Mei Songbo et al.
TOXICOLOGY LETTERS (2019)
Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence
Katarzyna Korzeniowska et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
Protective role of beta-blockers in chemotherapy-induced cardiotoxicitya systematic review and meta-analysis of carvedilol
Shan Huang et al.
HEART FAILURE REVIEWS (2019)
Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment
Fengfeng Cai et al.
MOLECULAR AND CLINICAL ONCOLOGY (2019)
Current and future therapeutic approaches for osteosarcoma
Douglas J. Harrison et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Adult-onset brain tumors and neurodegeneration: Are polyphenols protective?
Tiziana Squillaro et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kitposCD45negCD31neg cardiac stem cell activation
Cristina Carresi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Monica Samuel Avila et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes
Teresa Cunha-Oliveira et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
Jessica Marinello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cardiovascular Complications of Cancer Therapy Best Practices in Diagnosis, Prevention, and Management: Part 1
Hui-Ming Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Polyphenols, autophagy and doxorubicin-induced cardiotoxicity
S. Shabalala et al.
LIFE SCIENCES (2017)
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
Donato Cappetta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity
Alvaro Mordente et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity
Abdelrahman Ibrahim Abushouk et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Nutraceutical Properties of Olive Oil Polyphenols. An Itinerary from Cultured Cells through Animal Models to Humans
Stefania Rigacci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review
Kamal Razavi-Azarkhiavi et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2016)
Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity
Shreesh Ojha et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Hydroxytyrosol inhibits hydrogen peroxide-induced apoptotic signaling via labile iron chelation
Natalia Kitsati et al.
REDOX BIOLOGY (2016)
Glycation in Demetalated Superoxide Dismutase 1 Prevents Amyloid Aggregation and Produces Cytotoxic Ages Adducts
Vane Sirangelo et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2016)
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
Paweorn Angsutararux et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer
Sergio Granados-Principal et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression
Qinghua Dong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats
S. Imbaby et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2014)
Sesamol prevents doxorubicin-induced oxidative damage and toxicity on H9c2 cardiomyoblasts
Pawan G. Nayak et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Cellular Mechanisms Controlling Caspase Activation and Function
Amanda B. Parrish et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Anthracycline cardiotoxicity
Pierantonio Menna et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Functional characterization of osteosarcoma cell lines provides representative models to study the human disease
Alexander B. Mohseny et al.
LABORATORY INVESTIGATION (2011)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
Dexrazoxane-Associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease
Cameron K. Tebbi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Toxic proteins released from mitochondria in cell death
X Saelens et al.
ONCOGENE (2004)
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
P Spallarossa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis
WP Tsang et al.
LIFE SCIENCES (2003)
Doxorubicin-induced cardiac mitochondrionopathy
KB Wallace
PHARMACOLOGY & TOXICOLOGY (2003)
Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes
J Nitobe et al.
CARDIOVASCULAR RESEARCH (2003)
Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen - Role of reactive oxygen and nitrogen species
S Kotamraju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol
TM Li et al.
CIRCULATION (2000)
Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis
M Crompton
CURRENT OPINION IN CELL BIOLOGY (2000)